Comparative of in-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line
FA Gaballu, S Abbaspour-Ravasjani, B Mansoori… - 2019 - repository.brieflands.com
dc. description. abstract Erlotinib (ELT) as a small molecule with poor solubility, poor
bioavailability, and instability in gastrointestinal environment, has been considered as a …
bioavailability, and instability in gastrointestinal environment, has been considered as a …
[HTML][HTML] Comparative of in-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line
FA Gaballu, S Abbaspour-Ravasjani… - Iranian Journal of …, 2019 - brieflands.com
: Erlotinib (ELT) as a small molecule with poor solubility, poor bioavailability, and instability
in gastrointestinal environment, has been considered as a therapeutic agent for Non-Small …
in gastrointestinal environment, has been considered as a therapeutic agent for Non-Small …
[PDF][PDF] Comparative of in-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line
FA Gaballua, S Abbaspour-Ravasjanid… - Iranian Journal of …, 2019 - researchgate.net
Erlotinib (ELT) as a small molecule with poor solubility, poor bioavailability, and instability in
gastrointestinal environment, has been considered as a therapeutic agent for Non-Small …
gastrointestinal environment, has been considered as a therapeutic agent for Non-Small …
[PDF][PDF] Comparative of in-vitro Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell Line
FA Gaballua, S Abbaspour-Ravasjanid… - Iranian Journal of …, 2019 - sid.ir
Erlotinib (ELT) as a small molecule with poor solubility, poor bioavailability, and instability in
gastrointestinal environment, has been considered as a therapeutic agent for Non-Small …
gastrointestinal environment, has been considered as a therapeutic agent for Non-Small …